Heat shock protein masks BRCA1 mutations, suggesting a new treatment path

Researchers from The University of Texas MD Anderson Cancer Center identified a new role for heat shock protein 90 (HSP90) in cancer predisposition and treatment resistance.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup